4//SEC Filing
Pierce David A 4
Accession 0001225208-22-002694
CIK 0000885725other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 8:34 PM ET
Size
12.8 KB
Accession
0001225208-22-002694
Insider Transaction Report
Form 4
Pierce David A
SVP and President, Endoscopy
Transactions
- Exercise/Conversion
Common Stock
2022-02-15+2,769→ 2,769 total - Tax Payment
Common Stock
2022-02-15$44.01/sh−813$35,780→ 1,956 total - Sale
Common Stock
2022-02-16$43.81/sh−1,956$85,692→ 0 total - Exercise/Conversion
Deferred Stock Units
2022-02-15−2,769→ 2,769 totalExp: 2023-02-15→ Common Stock (2,769 underlying)
Footnotes (3)
- [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
- [F3]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001529751
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 8:34 PM ET
- Size
- 12.8 KB